Related Experiment Video

Updated: Aug 15, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

KAI1/CD82, a tumor metastasis suppressor

Wei M Liu1, Xin A Zhang

  • 1Vascular Biology Center and Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Cancer Letters
|November 2, 2005
PubMed

Insights

Tetraspanin KAI1/CD82 acts as a broad tumor metastasis suppressor by inhibiting cancer cell movement and invasion. Its loss in cancers is linked to epigenetic changes involving key transcription factors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tetraspanin KAI1/CD82 is recognized as a broad-spectrum suppressor of tumor metastasis.
  • KAI1/CD82 primarily functions by inhibiting cancer cell motility and invasiveness.
  • Within tetraspanin-enriched microdomains, KAI1/CD82 interacts with proteins crucial for cell migration.

Purpose of the Study:

  • To elucidate the mechanism by which KAI1/CD82 suppresses tumor metastasis.
  • To understand the association of KAI1/CD82 with motility-related proteins.
  • To investigate the epigenetic regulation of KAI1/CD82 expression in invasive cancers.

Main Methods:

  • Analysis of KAI1/CD82 protein interactions within tetraspanin-enriched microdomains.
  • Investigating the functional impact of KAI1/CD82 on cancer cell motility and invasiveness.
  • Examining the epigenetic mechanisms, including transcription factor involvement (NF-kappaB, p53, beta-catenin), underlying KAI1/CD82 expression loss.

Main Results:

  • KAI1/CD82 associates with cell adhesion molecules, growth factor receptors, and signaling molecules involved in cell migration.
  • KAI1/CD82 appears to down-regulate the functions of these motility-related proteins, thereby inhibiting cell migration.
  • Loss of KAI1/CD82 expression in invasive and metastatic cancers is associated with complex epigenetic mechanisms.

Conclusions:

  • KAI1/CD82 is a critical suppressor of tumor metastasis, acting by inhibiting cancer cell motility and invasiveness.
  • Epigenetic alterations, potentially involving transcription factors like NF-kappaB, p53, and beta-catenin, contribute to KAI1/CD82 expression loss in aggressive cancers.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...